269 related articles for article (PubMed ID: 25917568)
21. The Warburg effect as a therapeutic target for bladder cancers and intratumoral heterogeneity in associated molecular targets.
Burns JE; Hurst CD; Knowles MA; Phillips RM; Allison SJ
Cancer Sci; 2021 Sep; 112(9):3822-3834. PubMed ID: 34181805
[TBL] [Abstract][Full Text] [Related]
22. Molecular monitoring of epithelial-to-mesenchymal transition in breast cancer cells by means of Raman spectroscopy.
Marro M; Nieva C; Sanz-Pamplona R; Sierra A
Biochim Biophys Acta; 2014 Sep; 1843(9):1785-95. PubMed ID: 24747691
[TBL] [Abstract][Full Text] [Related]
23. Radiation driven epithelial-mesenchymal transition is mediated by Notch signaling in breast cancer.
Kim RK; Kaushik N; Suh Y; Yoo KC; Cui YH; Kim MJ; Lee HJ; Kim IG; Lee SJ
Oncotarget; 2016 Aug; 7(33):53430-53442. PubMed ID: 27462787
[TBL] [Abstract][Full Text] [Related]
24. Breast Cancer Subtypes Underlying EMT-Mediated Catabolic Metabolism.
Cho ES; Kim NH; Yun JS; Cho SB; Kim HS; Yook JI
Cells; 2020 Sep; 9(9):. PubMed ID: 32927665
[TBL] [Abstract][Full Text] [Related]
25. Exogenous normal mammary epithelial mitochondria suppress glycolytic metabolism and glucose uptake of human breast cancer cells.
Jiang XP; Elliott RL; Head JF
Breast Cancer Res Treat; 2015 Oct; 153(3):519-29. PubMed ID: 26407856
[TBL] [Abstract][Full Text] [Related]
26. Metabolic reprogramming in breast cancer results in distinct mitochondrial bioenergetics between luminal and basal subtypes.
Lunetti P; Di Giacomo M; Vergara D; De Domenico S; Maffia M; Zara V; Capobianco L; Ferramosca A
FEBS J; 2019 Feb; 286(4):688-709. PubMed ID: 30657636
[TBL] [Abstract][Full Text] [Related]
27. Long-term exposure of MCF-12A normal human breast epithelial cells to ethanol induces epithelial mesenchymal transition and oncogenic features.
Gelfand R; Vernet D; Bruhn K; Vadgama J; Gonzalez-Cadavid NF
Int J Oncol; 2016 Jun; 48(6):2399-414. PubMed ID: 27035792
[TBL] [Abstract][Full Text] [Related]
28. Aberrant cancer metabolism in epithelial-mesenchymal transition and cancer metastasis: Mechanisms in cancer progression.
Huang R; Zong X
Crit Rev Oncol Hematol; 2017 Jul; 115():13-22. PubMed ID: 28602165
[TBL] [Abstract][Full Text] [Related]
29. Lactate-activated macrophages induced aerobic glycolysis and epithelial-mesenchymal transition in breast cancer by regulation of CCL5-CCR5 axis: a positive metabolic feedback loop.
Lin S; Sun L; Lyu X; Ai X; Du D; Su N; Li H; Zhang L; Yu J; Yuan S
Oncotarget; 2017 Dec; 8(66):110426-110443. PubMed ID: 29299159
[TBL] [Abstract][Full Text] [Related]
30. The NQO1/PKLR axis promotes lymph node metastasis and breast cancer progression by modulating glycolytic reprogramming.
Yang Y; Zhu G; Dong B; Piao J; Chen L; Lin Z
Cancer Lett; 2019 Jul; 453():170-183. PubMed ID: 30954648
[TBL] [Abstract][Full Text] [Related]
31. Exploring the Metabolic Vulnerabilities of Epithelial-Mesenchymal Transition in Breast Cancer.
Sun X; Wang M; Wang M; Yao L; Li X; Dong H; Li M; Li X; Liu X; Xu Y
Front Cell Dev Biol; 2020; 8():655. PubMed ID: 32793598
[TBL] [Abstract][Full Text] [Related]
32. A Hidden Human Proteome Signature Characterizes the Epithelial Mesenchymal Transition Program.
Vergara D; Verri T; Damato M; Trerotola M; Simeone P; Franck J; Fournier I; Salzet M; Maffia M
Curr Pharm Des; 2020; 26(3):372-375. PubMed ID: 31995001
[TBL] [Abstract][Full Text] [Related]
33. UDP-glucose 6-dehydrogenase regulates hyaluronic acid production and promotes breast cancer progression.
Arnold JM; Gu F; Ambati CR; Rasaily U; Ramirez-Pena E; Joseph R; Manikkam M; San Martin R; Charles C; Pan Y; Chatterjee SS; Den Hollander P; Zhang W; Nagi C; Sikora AG; Rowley D; Putluri N; Zhang XH; Karanam B; Mani SA; Sreekumar A
Oncogene; 2020 Apr; 39(15):3089-3101. PubMed ID: 31308490
[TBL] [Abstract][Full Text] [Related]
34. Melatonin: an inhibitor of breast cancer.
Hill SM; Belancio VP; Dauchy RT; Xiang S; Brimer S; Mao L; Hauch A; Lundberg PW; Summers W; Yuan L; Frasch T; Blask DE
Endocr Relat Cancer; 2015 Jun; 22(3):R183-204. PubMed ID: 25876649
[TBL] [Abstract][Full Text] [Related]
35. EGFR Signal-Network Reconstruction Demonstrates Metabolic Crosstalk in EMT.
Choudhary KS; Rohatgi N; Halldorsson S; Briem E; Gudjonsson T; Gudmundsson S; Rolfsson O
PLoS Comput Biol; 2016 Jun; 12(6):e1004924. PubMed ID: 27253373
[TBL] [Abstract][Full Text] [Related]
36. Higher Glucose Enhances Breast Cancer Cell Aggressiveness.
Santos JM; Hussain F
Nutr Cancer; 2020; 72(5):734-746. PubMed ID: 31437005
[TBL] [Abstract][Full Text] [Related]
37. Metabolic profiling of breast cancer: Differences in central metabolism between subtypes of breast cancer cell lines.
Willmann L; Schlimpert M; Halbach S; Erbes T; Stickeler E; Kammerer B
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Sep; 1000():95-104. PubMed ID: 26218769
[TBL] [Abstract][Full Text] [Related]
38. Epithelial to mesenchymal transition (EMT) in metaplastic breast cancer and phyllodes breast tumors.
Akrida I; Mulita F; Plachouri KM; Benetatos N; Maroulis I; Papadaki H
Med Oncol; 2023 Dec; 41(1):20. PubMed ID: 38104042
[TBL] [Abstract][Full Text] [Related]
39. Exploring variations in glycolytic and gluconeogenic enzymes and isoforms across breast cancer cell lines and tissues.
Luís C; Fernandes R; Soares R
Carbohydr Res; 2024 Jul; 541():109169. PubMed ID: 38838492
[TBL] [Abstract][Full Text] [Related]
40. Epithelial-mesenchymal transition induction is associated with augmented glucose uptake and lactate production in pancreatic ductal adenocarcinoma.
Liu M; Quek LE; Sultani G; Turner N
Cancer Metab; 2016; 4():19. PubMed ID: 27777765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
